Page last updated: 2024-10-24

candesartan cilexetil and Coronary Stenosis

candesartan cilexetil has been researched along with Coronary Stenosis in 2 studies

candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects

Coronary Stenosis: Narrowing or constriction of a coronary artery.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Preumont, N1
Unger, P1
Goldman, S1
Berkenboom, G1
Yoshida, O1
Hirayama, H1
Nanasato, M1
Watanabe, T1
Murohara, T1

Trials

1 trial available for candesartan cilexetil and Coronary Stenosis

ArticleYear
The angiotensin II receptor blocker candesartan cilexetil reduces neointima proliferation after coronary stent implantation: a prospective randomized study under intravascular ultrasound guidance.
    American heart journal, 2005, Volume: 149, Issue:1

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Angiotensin II Type 1 Receptor Blockers; Benzimidaz

2005

Other Studies

1 other study available for candesartan cilexetil and Coronary Stenosis

ArticleYear
Effect of long-term angiotensin II type I receptor antagonism on peripheral and coronary vasomotion.
    Cardiovascular drugs and therapy, 2004, Volume: 18, Issue:3

    Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Belgium; Benzimidazoles; Biphenyl Com

2004